Publication

Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson’s disease

Downloadable Content

Persistent URL
Last modified
  • 03/14/2025
Type of Material
Authors
    Zhentao Zhang, Emory UniversitySeong Su Kang, Emory UniversityXia Liu, Emory UniversityEun Hee Ahn, Emory UniversityZhaohui Zhang, Renmin Hospital of Wuhan UniversityLi He, Emory UniversityP Michael Iuvone, Emory UniversityDuc M. Duong, Emory UniversityNicholas Seyfried, Emory UniversityMatthew J. Benskey, Michigan State UniversityFredric P. Manfredsson, Michigan State UniversityLingjing Jin, Tongji UniversityYi E. Sun, Tongji UniversityJian-Zhi Wang, Huazhong University of Science & TechnologyKeqiang Ye, Emory University
Language
  • English
Date
  • 2017-08-01
Publisher
  • Nature Publishing Group
Publication Version
Copyright Statement
  • © 2017 Nature America, Inc., part of Springer Nature. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1545-9993
Volume
  • 24
Issue
  • 8
Start Page
  • 632
End Page
  • +
Grant/Funding Information
  • This work was supported by grants from the Michael J. Fox Foundation (grant ID 11137) to K.Y.; a grant from the National Natural Science Foundation (NSFC) of China (no. 81571249) to Zhentao Zhang; NSFC grant (no. 81528007) to K.Y. and J.-Z.W.; a National Key Basic Research Program of China grant (2010CB945202) to Y.E.S.; an NSFC grant (81330030) to Y.E.S.; and grants from the US Public Health Service (P30EY006360 and R01EY004864) to P.M.I.
Supplemental Material (URL)
Abstract
  • Aggregated forms of α-synuclein play a crucial role in the pathogenesis of synucleinopathies such as Parkinson's disease (PD). However, the molecular mechanisms underlying the pathogenic effects of α-synuclein are not completely understood. Here we show that asparagine endopeptidase (AEP) cleaves human α-synuclein, triggers its aggregation and escalates its neurotoxicity, thus leading to dopaminergic neuronal loss and motor impairments in a mouse model. AEP is activated and cleaves human α-synuclein at N103 in an age-dependent manner. AEP is highly activated in human brains with PD, and it fragments α-synuclein, which is found aggregated in Lewy bodies. Overexpression of the AEP-cleaved α-synuclein 1-103 fragment in the substantia nigra induces both dopaminergic neuronal loss and movement defects in mice. In contrast, inhibition of AEP-mediated cleavage of α-synuclein (wild type and A53T mutant) diminishes α-synuclein's pathologic effects. Together, these findings support AEP's role as a key mediator of α-synuclein-related etiopathological effects in PD.
Author Notes
Keywords
Research Categories
  • Health Sciences, Pathology
  • Chemistry, Biochemistry
  • Biology, Neuroscience

Tools

Relations

In Collection:

Items